11
Participants
Start Date
June 30, 2009
Primary Completion Date
November 30, 2015
Study Completion Date
November 30, 2015
Bevacizumab
"* First treatment: 10 milligram per kilograms (MG/KG) intravenously (IV) on Day 1every two weeks over 90 minutes.~* Second treatment: 10 MG/KG IV on Day 1 every two weeks over 60 minutes.~* Third and subsequent treatments: 10 MG/KG IV on Day 1 every two weeks over 30 minutes (minimum of two cycles)."
Azacitidine
"* Dose level 1: 35 mg/m2/day for 7 days.~* Dose level 2: 55 mg/m2/day for 7 days.~* Dose level 3: 75 mg/m2/day for 7 days.~ * mg/m2/day = dose based on height and weight"
University of Kansas Medical Center, Kansas City
Stormont-Vail Cotton O'Neil Cancer Center, Topeka
Collaborators (1)
University of Kansas Medical Center
OTHER
Celgene
INDUSTRY